We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

149 hedge funds and large institutions have $862M invested in Dr. Reddy's Laboratories in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more call options, than puts

Call options by funds: $484K | Put options by funds: $363K

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

1% more funds holding

Funds holding: 148 → 149 (+1)

0.32% less ownership

Funds ownership: 64.56% → 64.24% (-0.32%)

1% less capital invested

Capital invested by funds: $870M → $862M (-$8.3M)

Holders
149
Holders Change
+1
Holders Change %
+0.68%
% of All Funds
3.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
48
Reduced
47
Closed
19
Calls
$484K
Puts
$363K
Net Calls
+$121K
Net Calls Change
+$215K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$12.8M
2
State Street
State Street
Massachusetts
+$12.1M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$12M
4
Renaissance Technologies
Renaissance Technologies
New York
+$11.9M
5
RG
Renaissance Group
Kentucky
+$9.54M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$23.5M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$14.5M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$8.26M
4
OAC
OMERS Administration Corp
Ontario, Canada
-$8.14M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
Carson Wealth (CWM LLC)
126
Carson Wealth (CWM LLC)
Nebraska
$36K – – –
GKIM
127
GW&K Investment Management
Massachusetts
$36K +$1.88K +225 +5%
FA
128
Forefront Analytics
Pennsylvania
$27.2K +$28.1K +3,370 New
AIG
129
American International Group
New York
$25K – – –
BCA
130
Berman Capital Advisors
Georgia
$19K +$3.54K +425 +22%
SCA
131
Stonebridge Capital Advisors
Minnesota
$16K – – –
EFSCE
132
Enterprise Financial Services Corp (EFSC)
Missouri
$12K +$3.67K +440 +40%
Mitsubishi UFJ Asset Management
133
Mitsubishi UFJ Asset Management
Japan
$11K – – –
PCG
134
Private Capital Group
Connecticut
$10K +$42 +5 +0.4%
TSW
135
Thompson Siegel & Walmsley
Virginia
$8K – – –
WAP
136
Wealthcare Advisory Partners
Pennsylvania
$7K – – –
LFG
137
Larson Financial Group
Missouri
$6K – – –
HIM
138
Hillsdale Investment Management
Ontario, Canada
$6K +$6.25K +750 New
FRA
139
Front Row Advisors
California
$4K -$3.25K -390 -52%
AIM
140
Aigen Investment Management
New York
$3K +$2.83K +340 New
PWMG
141
Prestige Wealth Management Group
New Jersey
$3K +$3.13K +375 +1,250%
PFGIA
142
Patriot Financial Group Insurance Agency
Massachusetts
$3K +$3.38K +405 New
EW
143
Evoke Wealth
California
$2.42K – – –
EARNEST Partners
144
EARNEST Partners
Georgia
$2K – – –
ABC
145
Associated Banc-Corp
Wisconsin
$2K +$2.42K +290 New
FGAM
146
Financial Gravity Asset Management
Texas
$1.41K +$667 +80 +84%
Fifth Third Bancorp
147
Fifth Third Bancorp
Ohio
$1K – – –
VanEck Associates
148
VanEck Associates
New York
$1K +$1.33K +160 New
ASN
149
Advisory Services Network
Georgia
$1K +$1.46K +175 New
Acadian Asset Management
150
Acadian Asset Management
Massachusetts
– -$8.26M -1,017,740 Closed
3 4 5
6
7

RDY Hedge Fund Activity: Q1 2020 in Review

149 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2020, worth a combined $862M — down 0.95% from $870M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new RDY positions and 19 closed out — a net gain of 3 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $12.8M. The largest seller was BlackRock, cutting an estimated $23.5M.

  • 149 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2020, up from 148 in Q4 2019.
  • Funds reported $862M of Dr. Reddy's Laboratories stock for Q1 2020, down 0.95% quarter-over-quarter.
  • 22 funds opened new Dr. Reddy's Laboratories positions in Q1 2020 and 19 closed out, a net change of +3 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q1 2020 was Goldman Sachs, an estimated $12.8M added.
  • The largest Dr. Reddy's Laboratories seller in Q1 2020 was BlackRock, an estimated $23.5M sold.

Based on aggregated 13F filings for Q1 2020.